News
ADHD: GPs are told to review some patients amid drug shortages
BMJ 2023; 382 doi: https://doi.org/10.1136/bmj.p2250 (Published 28 September 2023) Cite this as: BMJ 2023;382:p2250- Elisabeth Mahase
- The BMJ
GPs have been advised not to start new patients on several drugs for treating attention deficit/hyperactivity disorder that are in short supply in the UK, said the Department of Health and Social Care, because of a combination of manufacturing problems and increasing global demand.
Drugs affected by the disruption, which is expected to last until the end …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.